Skip to content

Clinical trials

Phase 4 Hepatitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Phase 4 Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20052
20062
20082
20091
20112
20122
20133
20142
20152
20171
20181
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status8
Active, not recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centers for Disease Control and Prevention2
Kirby Institute2
Merck Sharp & Dohme LLC2
National Taiwan University Hospital2
Asan Medical Center1
Chuncheon Sacred Heart Hospital1
Cttq1
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León1
Gilead Sciences1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis28
Hepatitis B6
Hepatitis C5
Hepatitis C, Chronic4
Hepatitis A3
Hepatitis B, Chronic3
Acquired Immunodeficiency Syndrome2
Anemia, Hemolytic1
Coinfection1
Digestive System Diseases1

Trials

Showing 51 to 28 of 28. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.